Driehaus Capital Management LLC Tyra Biosciences, Inc. Transaction History

Driehaus Capital Management LLC

  • $10.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$11.01 - $14.95 $586,183 - $795,952
53,241 Added 35.38%
203,709 $2.82 Million
Q2 2023

Aug 14, 2023
BUY
$11.99 - $17.51 $195,377 - $285,325
16,295 Added 12.14%
150,468 $2.56 Million
Q1 2023

May 15, 2023
BUY
$6.85 - $16.22 $919,085 - $2.18 Million
134,173 New
134,173 $2.16 Million

Others Institutions Holding TYRA

# of Institutions
98
Shares Held
43.5M
Call Options Held
353K
Put Options Held
1.1K
View Full List

About Tyra Biosciences, Inc.

TYRA Quotes by TradingView
  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $646M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email